Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Annals of Plastic Surgery|January 25, 2008
A heterotopic primate model for facial composite tissue transplantationRonald P Silverman, Nia D Banks, Louis J Detolla, et al.
Science Translational Medicine|February 18, 2021
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular functionMonica Xiong, Hong Jiang, Javier Remolina Serrano, et al.
The Journal of Arthroplasty|March 30, 2021
The Effectiveness of Closed-Incision Negative-Pressure Therapy Versus Silver-Impregnated Dressings in Mitigating Surgical Site Complications in High-Risk Patients After Revision Knee Arthroplasty: The PROMISES Randomized Controlled TrialCarlos A Higuera-Rueda, Ahmed K Emara, Yeni Nieves-Malloure, et al.
Acta Neuropathologica|August 13, 2008
The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndromeJerzy Wegiel, Karol Dowjat, Wojciech Kaczmarski, et al.
Molecular Genetics and Metabolism|July 18, 2023
An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tractKristen Skvorak, Vesna Mitchell, Leann Teadt, et al.
Scientific Reports|March 24, 2023
Optimizing human α-galactosidase for treatment of Fabry diseaseWilliam C Hallows, Kristen Skvorak, Nick Agard, et al.
Journal of Inherited Metabolic Disease|July 26, 2023
Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primatesKristen Skvorak, Joyce Liu, Nikki Kruse, et al.
Acta Neuropathologica|January 24, 2007
Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degenerationJerzy Wegiel, Izabela Kuchna, Krzysztof Nowicki, et al.
Journal of Neuropathology and Experimental Neurology|December 16, 2010
Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndromeJerzy Wegiel, Wojciech Kaczmarski, Madhabi Barua, et al.
Plos One|June 24, 2025
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C Wei, Aaron J Cantor, Jack Walleshauser, et al.
Pageof 21